Advertising for medicines: promoting while complying with French regulations
Post-marketing pharmacovigilance obligations in Europe
How to market a drug in France? Centralized Marketing Authorization and other cases
Early access and compassionate use: making a drug available when not authorized in France
What are the EMA’s timelines for the standard and accelerated procedures?
Understanding the differences between the FDA and the EMA: strategic implications for market access
Pharmaceutical patents: how to protect the intellectual property of a healthcare innovation?
Requirements for compliant manufacturing of biotechnological products
How to manage regulatory variations of a Marketing Authorisation (MA)?
What are the upcoming changes for biosimilar medicines in the European Union?
Strategies to reduce drug development time
What are the EMA’s requirements for clinical trials?